The C terminus of apolipoprotein A-V modulates lipid-binding activity. 2007

Jennifer A Beckstead, and Kasuen Wong, and Vinita Gupta, and Chung-Ping L Wan, and Victoria R Cook, and Richard B Weinberg, and Paul M M Weers, and Robert O Ryan
Center for Prevention of Obesity, Diabetes, and Cardiovascular Disease, Children's Hospital Oakland Research Institute, Oakland, California 94609, USA.

Human apolipoprotein A-V (apoA-V) is a potent modulator of plasma triacylglycerol (TG) levels. To probe different regions of this 343-amino-acid protein, four single Trp apoA-V variants were prepared. The variant with a Trp at position 325, distal to the tetraproline sequence at residues 293-296, displayed an 11-nm blue shift in wavelength of maximum fluorescence emission upon lipid association. To evaluate the structural and functional role of this C-terminal segment, a truncated apoA-V comprising amino acids 1-292 was generated. Far UV circular dichroism spectra of full-length apoA-V and apoA-V-(1-292) were similar, with approximately 50% alpha-helix content. In guanidine HCl denaturation experiments, both full-length and truncated apoA-V yielded biphasic profiles consistent with the presence of two structural domains. The denaturation profile of the lower stability component (but not the higher stability component) was affected by truncation. Truncated apoA-V displayed an attenuated ability to solubilize l-alpha-dimyristoylphosphatidylcholine phospholipid vesicles compared with full-length apoA-V, whereas a peptide corresponding to the deleted C-terminal segment displayed markedly enhanced kinetics. The data support the concept that the C-terminal region is not required for apoA-V to adopt a folded protein structure, yet functions to modulate apoA-V lipid-binding activity; therefore, this concept may be relevant to the mechanism whereby apoA-V influences plasma TG levels.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008081 Liposomes Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins. Niosomes,Transferosomes,Ultradeformable Liposomes,Liposomes, Ultra-deformable,Liposome,Liposome, Ultra-deformable,Liposome, Ultradeformable,Liposomes, Ultra deformable,Liposomes, Ultradeformable,Niosome,Transferosome,Ultra-deformable Liposome,Ultra-deformable Liposomes,Ultradeformable Liposome
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002942 Circular Dichroism A change from planar to elliptic polarization when an initially plane-polarized light wave traverses an optically active medium. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Circular Dichroism, Vibrational,Dichroism, Circular,Vibrational Circular Dichroism
D004134 Dimyristoylphosphatidylcholine A synthetic phospholipid used in liposomes and lipid bilayers for the study of biological membranes. Dimyristoyllecithin,1,2-Dimyristoyl-glycero-3-phosphorylcholine,1,2-Ditetradecanoyl-glycero-3-phosphocholine,1,2-Ditetradecyl-glycero-3-phosphocholine,DMCP,DMPC,1,2 Dimyristoyl glycero 3 phosphorylcholine,1,2 Ditetradecanoyl glycero 3 phosphocholine,1,2 Ditetradecyl glycero 3 phosphocholine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072040 Apolipoprotein A-V A minor apolipoprotein that associates with HIGH-DENSITY LIPOPROTEINS (HDL), VERY-LOW-DENSITY LIPOPROTEINS (VLDL), and CHYLOMICRONS. It regulates levels of plasma TRIGLYCERIDES by activating APOLIPOPROTEIN C-II LIPOPROTEIN LIPASE and inhibiting hepatic VLDL triglyceride hydrolysis. APOA5 Protein,Apo A-V Protein,Apo A5 Protein,ApoA-V Protein,Apolipoprotein A5,Apo A V Protein,ApoA V Protein,Apolipoprotein A V
D001054 Apolipoproteins A Structural proteins of the alpha-lipoproteins (HIGH DENSITY LIPOPROTEINS), including APOLIPOPROTEIN A-I and APOLIPOPROTEIN A-II. They can modulate the activity of LECITHIN CHOLESTEROL ACYLTRANSFERASE. These apolipoproteins are low in atherosclerotic patients. They are either absent or present in extremely low plasma concentration in TANGIER DISEASE. Apo-A,ApoA
D014280 Triglycerides An ester formed from GLYCEROL and three fatty acid groups. Triacylglycerol,Triacylglycerols,Triglyceride

Related Publications

Jennifer A Beckstead, and Kasuen Wong, and Vinita Gupta, and Chung-Ping L Wan, and Victoria R Cook, and Richard B Weinberg, and Paul M M Weers, and Robert O Ryan
May 2017, Journal of lipid research,
Jennifer A Beckstead, and Kasuen Wong, and Vinita Gupta, and Chung-Ping L Wan, and Victoria R Cook, and Richard B Weinberg, and Paul M M Weers, and Robert O Ryan
March 2009, Biochemistry,
Jennifer A Beckstead, and Kasuen Wong, and Vinita Gupta, and Chung-Ping L Wan, and Victoria R Cook, and Richard B Weinberg, and Paul M M Weers, and Robert O Ryan
August 2005, The Journal of biological chemistry,
Jennifer A Beckstead, and Kasuen Wong, and Vinita Gupta, and Chung-Ping L Wan, and Victoria R Cook, and Richard B Weinberg, and Paul M M Weers, and Robert O Ryan
January 1998, Biochimica et biophysica acta,
Jennifer A Beckstead, and Kasuen Wong, and Vinita Gupta, and Chung-Ping L Wan, and Victoria R Cook, and Richard B Weinberg, and Paul M M Weers, and Robert O Ryan
November 2006, Atherosclerosis,
Jennifer A Beckstead, and Kasuen Wong, and Vinita Gupta, and Chung-Ping L Wan, and Victoria R Cook, and Richard B Weinberg, and Paul M M Weers, and Robert O Ryan
April 1969, Biochimica et biophysica acta,
Jennifer A Beckstead, and Kasuen Wong, and Vinita Gupta, and Chung-Ping L Wan, and Victoria R Cook, and Richard B Weinberg, and Paul M M Weers, and Robert O Ryan
April 1995, The Journal of biological chemistry,
Jennifer A Beckstead, and Kasuen Wong, and Vinita Gupta, and Chung-Ping L Wan, and Victoria R Cook, and Richard B Weinberg, and Paul M M Weers, and Robert O Ryan
February 2017, Biochimica et biophysica acta. Bioenergetics,
Jennifer A Beckstead, and Kasuen Wong, and Vinita Gupta, and Chung-Ping L Wan, and Victoria R Cook, and Richard B Weinberg, and Paul M M Weers, and Robert O Ryan
August 2005, Journal of lipid research,
Jennifer A Beckstead, and Kasuen Wong, and Vinita Gupta, and Chung-Ping L Wan, and Victoria R Cook, and Richard B Weinberg, and Paul M M Weers, and Robert O Ryan
July 2007, Journal of lipid research,
Copied contents to your clipboard!